{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:54:55Z","timestamp":1787961295032,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To evaluate the diagnostic value of exfoliated tumor cells (ETCs) numbers combined with DNA methylation levels in bronchoalveolar lavage fluid (BALF) in lung cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>BALF samples were collected from 43 patients with lung cancer and 23 with benign lung disease. ETCs were detected by the nano-enrichment method, and the methylation status of the short stature homeobox gene 2 (SHOX2) and the RAS association domain family 1, isoform A (RASSF1A) gene were detected by RT-PCR. The diagnostic value of each metric was evaluated by receiver operating characteristic curve analysis, specificity and sensitivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The sensitivity\/specificity of RASSF1A and SHOX2 methylation detection were 44.12%\/76.47% and 93.75%\/87.50%, respectively. When \u201cRASSF1A\/SHOX2 methylation\u201d was used as a positive result, the sensitivity increased to 88.24%, and the specificity decreased to 81.25%. When \u201cRASSF1A\u2005+\u2005SHOX methylation\u201d was used as positive, the sensitivity was reduced to 32.35%, but the specificity was increased to 100.00%. The sensitivity and specificity of ETCs detection in BALF were 89.47% and 16.67%, respectively. When \u201cSHOX2\/RASSF1A methylation\u2005+\u2005ETCs was used as a positive result, the sensitivity and specificity of the detection were 79.31% and 81.82%, respectively. When \u201cSHOX2\u2005+\u2005RASSF1A\u2005+\u2005ETCs\u201d was used as positive, the sensitivity was 34.48% and the specificity was 90.91%. Receiver operating characteristic curve analysis showed that when SHOX2, RASSF1A methylation and ETCs were combined, the diagnostic sensitivity increased to 0.778.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>ETCs counting in combination with SHOX2 and RASSF1A methylation assays in BALF samples has demonstrated excellent sensitivity for lung cancer diagnosis and is an effective complementary tool for clinical diagnosis of lung cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034955","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T14:05:00Z","timestamp":1694181900000},"page":"e34955","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer"],"prefix":"10.1097","volume":"102","author":[{"given":"Huiling","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Affiliated Suzhou Municipal Hospital of Nanjing Medical University, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-9162","authenticated-orcid":false,"given":"Dang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Affiliated Suzhou Municipal Hospital of Nanjing Medical University, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3945\/an.116.012211","article-title":"World Cancer Report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015.","volume":"7","author":"McGuire","year":"2016","journal-title":"Adv Nutr"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/JTO.0000000000000282","article-title":"A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis.","volume":"9","author":"Uribarri","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.21037\/jtd.2016.11.06","article-title":"Shifted focus of bronchoalveolar lavage in patients with suspected thoracic malignancy: an analysis of 224 patients.","volume":"8","author":"Zhang","year":"2016","journal-title":"J Thorac Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCP.0000000000000398","article-title":"Bronchoscopic modalities to diagnose sarcoidosis.","volume":"23","author":"Benzaquen","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/pr.2015.193","article-title":"DNA methylation, early life environment, and health outcomes.","volume":"79","author":"Mitchell","year":"2016","journal-title":"Pediatr Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/gtmb.2014.0022","article-title":"Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.","volume":"18","author":"Si","year":"2014","journal-title":"Genet Test Mol Biomarkers"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","article-title":"Diagnostic power of DNA methylation classifiers for early detection of cancer.","volume":"6","author":"Roy","year":"2020","journal-title":"Trends Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"849024","DOI":"10.3389\/fonc.2022.849024","article-title":"The diagnostic potential of SHOX2 and RASSF1A DNA methylation in early lung adenocarcinoma.","volume":"12","author":"Gao","year":"2022","journal-title":"Front Oncol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.7150\/jca.21368","article-title":"DNA methylation analysis of the SHOX2 and RASSF1A panel in bronchoalveolar lavage fluid for lung cancer diagnosis.","volume":"8","author":"Zhang","year":"2017","journal-title":"J Cancer"},{"issue":"Suppl 7","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.21037\/jtd.2017.12.125","article-title":"Performance evaluation of detecting circulating tumor cells and tumor cells in bronchoalveolar lavage fluid in diagnosis of peripheral lung cancer.","volume":"10","author":"Zhong","year":"2018","journal-title":"J Thorac Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-2007-991526","article-title":"Bronchoalveolar lavage in malignancy.","volume":"28","author":"Poletti","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.7150\/thno.44274","article-title":"A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer \u2018PERFECT\u2019 filter system.","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/ijc.33140","article-title":"Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients.","volume":"147","author":"Batth","year":"2020","journal-title":"Int J Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e78070","DOI":"10.1371\/journal.pone.0078070","article-title":"Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1039\/C8LC01048J","article-title":"A high-throughput liquid biopsy for rapid rare cell separation from large-volume samples.","volume":"19","author":"Liu","year":"2018","journal-title":"Lab Chip"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e0219129","DOI":"10.1371\/journal.pone.0219129","article-title":"The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.","volume":"14","author":"Wei","year":"2019","journal-title":"PLoS One"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance.","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1021\/am505201s","article-title":"Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells.","volume":"6","author":"Wan","year":"2014","journal-title":"ACS Appl Mater Interfaces"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/588203","article-title":"Using samples to estimate the sensitivity and specificity of a surveillance process.","volume":"29","author":"McBryde","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e24179","DOI":"10.1002\/jcla.24179","article-title":"Diagnostic value of periostin in lung cancer-related malignant pleural effusion.","volume":"36","author":"Zhang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"565780","DOI":"10.3389\/fonc.2020.565780","article-title":"Performance evaluation of SHOX2 and RASSF1A methylation for the aid in diagnosis of lung cancer based on the analysis of FFPE specimen.","volume":"10","author":"Shi","year":"2020","journal-title":"Front Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40291-015-0144-5","article-title":"Diagnosis of lung cancer by SHOX2 gene methylation assay.","volume":"19","author":"Song","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/OTT.S124417","article-title":"RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.","volume":"10","author":"Shou","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.7314\/APJCP.2014.15.12.4925","article-title":"Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer.","volume":"15","author":"Zhai","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","article-title":"DNA methylation cancer biomarkers: translation to the clinic.","volume":"10","author":"Locke","year":"2019","journal-title":"Front Genet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fonc.2014.00242","article-title":"Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system.","volume":"4","author":"Truini","year":"2014","journal-title":"Front Oncol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00408-015-9697-7","article-title":"Circulating tumor cells in lung cancer: detection methods and clinical applications.","volume":"193","author":"Yu","year":"2015","journal-title":"Lung"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/0973-1482.162111","article-title":"Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer.","volume":"12","author":"Wang","year":"2016","journal-title":"J Cancer Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:28:01Z","timestamp":1746325681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":29,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034955","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}